SCHEMBL455753

SCHEMBL455753

O=C1NC(=O)C2CC12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18545242 1.00 MAP3K14 (0.33)
SCHEMBL3628793 1.00 MAP3K14 (0.33)
SCHEMBL5909395 0.84 ALDH1A1 (0.31)
SCHEMBL2548921 0.82 CRBN (0.36)
SCHEMBL6016837 0.82 MEN1 (0.30)
SCHEMBL2548118 0.82 CRBN (0.36)
SCHEMBL3842201 0.82
SCHEMBL10615877 0.82 KDM4E (0.33)
SCHEMBL21880340 0.82 CRBN (0.42)
SCHEMBL16364840 0.80 ACHE (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4452984-A1 DEUBIQUITINASE INHIBITORS AND METHODS OF USE THEREOF Molecure S.A. (PL) 2024-10-30 EP claimed
US-20230219973-A1 DEUBIQUITINASE INHIBITORS AND METHODS OF USE THEREOF MOLECURE S.A. (PL) 2023-07-13 US claimed
WO-2023119233-A1 DEUBIQUITINASE INHIBITORS AND METHODS OF USE THEREOF MOLECURE S.A. (PL) 2023-06-29 WO claimed
US-7112586-B2 Substituted diamine derivatives useful as motilin antagonists ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2006-09-26 US claimed
US-20050148584-A1 Novel substituted diamine derivatives useful as motilin antagonists JOHNSON SIGMOND G (US) 2005-07-07 US claimed
US-20030203906-A1 A phenylamide derivatives for treating gastrointestinal reflux disorders, eating disorder obesity and irritable bowel disorder JOHNSON SIGMONG G (US) 2003-10-30 US claimed
EP-1294695-A2 SUBSTITUTED DIAMIDE DERIVATIVES USEFUL AS MOTILIN ANTAGONISTS Ortho-McNeil Pharmaceutical, Inc. (US) 2003-03-26 EP claimed
US-20020013352-A1 For therapy of gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel disorder ORTHO-MCNEIL PHARMACEUTICAL, INC. 2002-01-31 US claimed
WO-2001085694-A2 SUBSTITUTED DIAMIDE DERIVATIVES USEFUL AS MOTILIN ANTAGONISTS ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2001-11-15 WO claimed
EP-0011321-A1 Pyrrolidine derivatives and process for the preparation of such compounds SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1980-05-28 EP claimed
JP-10067741-A None JP disclosed
EP-4688740-A1 FUSED PYRROLIDINE-2-ONE HERBICIDAL COMPOUNDS Syngenta Crop Protection AG (CH) 2026-02-11 EP disclosed
EP-4230264-B1 PRODRUGS OF FUMARATES AND THEIR USE IN TREATING VARIOUS DESEASES ALKERMES PHARMA IRELAND LTD (IE) 2026-01-28 EP disclosed
US-12404279-B2 Deubiquitinase inhibitors and methods of use thereof MOLECURE S.A. (PL) 2025-09-02 US disclosed
WO-2025106362-A1 RIPK1 INHIBITORS AND METHODS OF USE MERCK SHARP & DOHME LLC (US) 2025-05-22 WO disclosed
EP-0818446-A1 Process for preparing 2,4-dioxo-3-azabicyclo(3.1.0)hexanes Pfizer Limited (GB) 1998-01-14 EP disclosed
EP-0685995-A1 ENHANCER COMPOSITION FOR AGRICULTURAL CHEMICALS AND AGRICULTURAL CHEMICAL COMPOSITION Kao Corporation (JP) 1995-12-13 EP disclosed
WO-1995017817-A1 ENHANCER COMPOSITION FOR AGRICULTURAL CHEMICALS AND AGRICULTURAL CHEMICAL COMPOSITION KAO CORPORATION (JP) 1995-07-06 WO disclosed
EP-0011321-A1 Pyrrolidine derivatives and process for the preparation of such compounds SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1980-05-28 EP disclosed
EP-0011321-A1 Pyrrolidine derivatives and process for the preparation of such compounds SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1980-05-28 EP disclosed